documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

43 rows where agency_id = "FDA" and docket_id = "FDA-2005-N-0464" sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: subtype, posted_date, posted_month, comment_start_date, comment_end_date, fr_doc_num, open_for_comment, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)

posted_year 7

agency_id 1

  • FDA · 43 ✖
id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2005-N-0464-0249 FDA Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs FDA-2005-N-0464 Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs That Are Regulated Under a Biologics License Application, and Animal Drugs; Corrections Rule Final Rule 2021-04-01T04:00:00Z 2021 4 2021-04-01T04:00:00Z   2021-04-01T15:35:43Z 2021-06677 0 0 0900006484a93032
FDA-2005-N-0464-0244 FDA Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs FDA-2005-N-0464 Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Establishment Registration of Producers of Drugs and Listing of Drugs in Commercial Distribution and Blood Establishment Registration and Product Listing Notice Announcement 2017-04-25T04:00:00Z 2017 4 2017-04-25T04:00:00Z   2017-04-25T14:08:22Z 2017-08305 0 0 090000648257352e
FDA-2005-N-0464-0241 FDA Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs FDA-2005-N-0464 Tab 3: Draft Final Economic Impact Analysis for a Prospective FDA Rule Governing: Foreign and Domestic Establishment Registration and Listing Requirements for Human Drugs, Certain Biological Drugs, and Animal Drugs - dated on 08/03/2005 Supporting & Related Material Background Material 2017-01-09T05:00:00Z 2017 1     2017-08-15T14:19:34Z   0 0 0900006480450bff
FDA-2005-N-0464-0243 FDA Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs FDA-2005-N-0464 Tab 5: Cost Impacts of the Over-the-Counter Pharmaceutical Labeling Rule - final report dated on 03/05/1999 Supporting & Related Material Background Material 2017-01-09T05:00:00Z 2017 1     2017-08-15T14:26:29Z   0 0 0900006480450bfe
FDA-2005-N-0464-0242 FDA Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs FDA-2005-N-0464 Tab 4: Profile of the Prescription drug wholesaling Industry: Examination of Entities Defining Supply and Demand in Drug Distribution - Final Report dated on 02/12/2001 Supporting & Related Material Background Material 2017-01-09T05:00:00Z 2017 1     2017-08-15T14:24:05Z   0 0 0900006480450bfa
FDA-2005-N-0464-0240 FDA Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs FDA-2005-N-0464 Tab 2: Letter from FDA/CDER to Eugene S. Peiser & Associates Dated on 08/25/1997 Supporting & Related Material Background Material 2017-01-09T05:00:00Z 2017 1     2017-08-15T14:16:37Z   0 0 0900006480450bf8
FDA-2005-N-0464-0239 FDA Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs FDA-2005-N-0464 Tab 1: Letter from National Association of CHAIN DRUG STORES(NACDS) to FDA/CDER on 09/27/2004 Supporting & Related Material Background Material 2017-01-09T05:00:00Z 2017 1     2017-08-15T14:13:32Z   0 0 0900006480450bfc
FDA-2005-N-0464-0238 FDA Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs FDA-2005-N-0464 Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs That Are Regulated Under a Biologics License Application, and Animal Drugs; Correction Rule Final Rule 2016-12-13T05:00:00Z 2016 12 2016-12-13T05:00:00Z   2016-12-13T14:31:48Z 2016-29774 0 0 09000064823fed93
FDA-2005-N-0464-0235 FDA Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs FDA-2005-N-0464 Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that Are Regulated Under a Biologics License Application, and Animal Drugs Supporting & Related Material Background Material 2016-08-31T04:00:00Z 2016 8     2016-08-31T14:33:56Z   0 0 09000064821b7bb5
FDA-2005-N-0464-0237 FDA Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs FDA-2005-N-0464 Ref2_ERG Revisions 1995 DRAFT FINAL REPORT ECONOMIC THRESHOLD AND REGULATORY FLEXIBILITY ASSESSMENT OF PROPOSED CHANGES TO THE CURRENT GOOD MANUFACTURING PRACTICE REGULATIONS FOR MANUFACTURING, PROCESSING, PACKING, OR HOLDING DRUGS (21CFR210&211) re Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under Supporting & Related Material Background Material 2016-08-31T04:00:00Z 2016 8     2016-08-31T14:37:59Z   0 0 09000064821b7bb7
FDA-2005-N-0464-0236 FDA Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs FDA-2005-N-0464 Ref1_BLS_wages_May_2014_NAICS325400 - Pharmaceutical and Medicine Manufacturing re Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs Supporting & Related Material Background Material 2016-08-31T04:00:00Z 2016 8     2016-08-31T14:36:09Z   0 0 09000064821b7bb6
FDA-2005-N-0464-0234 FDA Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs FDA-2005-N-0464 Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs That Are Regulated Under a Biologics License Application, and Animal Drugs Rule Final Rule 2016-08-31T04:00:00Z 2016 8 2016-08-31T04:00:00Z   2016-08-31T14:21:07Z 2016-20471 0 0 09000064821b68af
FDA-2005-N-0464-0232 FDA Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs FDA-2005-N-0464 Guidance for Industry on Providing Regulatory Submissions in Electronic Format-Drug Establishment Registration and Drug Listing; Availability Notice NAD-Notice of Availability of Data 2009-06-01T04:00:00Z 2009 6 2009-06-01T04:00:00Z 2009-06-02T03:59:59Z 2010-08-13T15:19:06Z E9-12743 0 0 09000064809c1db8
FDA-2005-N-0464-0231 FDA Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs FDA-2005-N-0464 Guideline re Guidance for Industry on Providing Regulatory Submissions in Electronic Format-Drug Establishment Registration and Drug Listing; Availability Other Guidance 2009-06-01T04:00:00Z 2009 6 2009-06-01T04:00:00Z   2016-12-08T18:55:55Z   0 0 09000064809c15da
FDA-2005-N-0464-0230 FDA Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs FDA-2005-N-0464 Notice of Availability of Data re Guidance for Industry on Providing Regulatory Submissions in Electronic Format-Drug Establishment Registration and Drug Listing; Availability Notice Notice of Availability 2009-06-01T04:00:00Z 2009 6 2009-06-01T04:00:00Z 2009-06-02T03:59:59Z 2020-10-10T01:01:27Z E9-12743 0 0 09000064809c0c71
FDA-2005-N-0464-0233 FDA Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs FDA-2005-N-0464 Providing Regulatory Submissions in Electronic Format – Drug Establishment Registration and Drug Listing Other Guidance 2009-05-28T04:00:00Z 2009 5 2009-05-28T04:00:00Z   2020-10-10T01:01:01Z   0 0 09000064809c1ad2
FDA-2005-N-0464-0229 FDA Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs FDA-2005-N-0464 Compressed Gas Association - Supplement Comment [re FDA-2005-N-0464-0080.1] Other SUP-Supplement 2009-04-16T04:00:00Z 2009 4 2009-04-16T04:00:00Z   2014-12-16T22:17:42Z   0 0 090000648095560b
FDA-2005-N-0464-0222 FDA Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs FDA-2005-N-0464 Hospira Inc. - "The Proposed Changes to NDC System Legacy NDC Numbers and Compliance " (Thomas F. Willer) - Testimony Other TS-Testimony 2009-04-15T04:00:00Z 2009 4 2009-04-15T04:00:00Z   2017-01-18T17:36:54Z   0 0 0900006480450c46
FDA-2005-N-0464-0223 FDA Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs FDA-2005-N-0464 Perrigo - "Experience with NDC Numbers" - Testimony Other TS-Testimony 2009-04-15T04:00:00Z 2009 4 2009-04-15T04:00:00Z   2017-01-18T17:38:31Z   0 0 0900006480450c48
FDA-2005-N-0464-0224 FDA Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs FDA-2005-N-0464 Consumer Healthcare Products Association (CHPA) - ""FDA Public Meeting – Proposed Changes to the National Drug Code (NDC) Number System" (Paul J. Larsen) - Testimony Other TS-Testimony 2009-04-15T04:00:00Z 2009 4 2009-04-15T04:00:00Z   2017-01-18T17:40:20Z   0 0 0900006480450c4a
FDA-2005-N-0464-0226 FDA Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs FDA-2005-N-0464 Guidance for Industry Providing Regulatory Submissions in Electronic Format -Drug Establishment Registration and Drug Listing Other GDL-Guidance (Supporting and Related Materials) 2009-04-15T04:00:00Z 2009 4 2009-04-15T04:00:00Z   2019-10-17T19:56:23Z   0 0 0900006480667d76
FDA-2005-N-0464-0225 FDA Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs FDA-2005-N-0464 AABB - "National Drug Codes for HCT/Ps" (M. Allene Carr-Greer) - Testimony Other TS-Testimony 2009-04-15T04:00:00Z 2009 4 2009-04-15T04:00:00Z   2017-01-18T17:41:41Z   0 0 0900006480450c4f
FDA-2005-N-0464-0220 FDA Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs FDA-2005-N-0464 Notice re Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Draft Guidance for Industry on Providing Regulatory Submissions in Electronic Format--Drug Establishment Registration and Drug Listing Notice General Notice 2008-10-23T04:00:00Z 2008 10     2016-12-08T19:05:18Z E8-25338 0 0 090000648077419a
FDA-2005-N-0464-0150 FDA Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs FDA-2005-N-0464 Shipping Label re Comment from Bristol-Myers Squibb Company Supporting & Related Material Transmittals 2008-09-12T04:00:00Z 2008 9     2016-11-17T18:18:40Z   0 0 0900006480450d18
FDA-2005-N-0464-0073 FDA Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs FDA-2005-N-0464 Background Material re The Compressed Gas Assaciation (CCA) and the Gases and Welding Distributors Association (GAWDA) Supporting & Related Material Background Material 2008-09-10T04:00:00Z 2008 9     2017-08-14T19:23:12Z   0 0 0900006480450c6f
FDA-2005-N-0464-0030 FDA Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs FDA-2005-N-0464 Request Extension of Comment Period from Compressed Gas Association Other EXT-Request for Extension Comment Due Date 2008-09-09T04:00:00Z 2008 9 2006-08-23T04:00:00Z 2006-11-28T04:59:59Z 2017-07-21T16:15:19Z   0 0 0900006480450c0c
FDA-2005-N-0464-0034 FDA Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs FDA-2005-N-0464 Request for Extension re Comment from L. Perrigo Company Other Request for Extension 2008-09-09T04:00:00Z 2008 9 2006-08-23T04:00:00Z 2006-11-28T04:59:59Z 2016-12-13T20:38:04Z   0 0 0900006480450c13
FDA-2005-N-0464-0033 FDA Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs FDA-2005-N-0464 Request for Extension re Comment from Consumer Healthcare Products Association (CHPA) Other Request for Extension 2008-09-09T04:00:00Z 2008 9 2006-08-23T04:00:00Z 2006-11-28T04:59:59Z 2017-08-14T20:26:17Z   0 0 0900006480450c12
FDA-2005-N-0464-0022 FDA Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs FDA-2005-N-0464 Notice of Data Availability re Draft Guidance for Industry on Providing Regulatory Submissions in Electronic Format--Drug Establishment Registration and Drug Listing; Availability Notice Notice of Data Availability 2008-07-11T04:00:00Z 2008 7 2008-07-11T04:00:00Z 2008-09-10T03:59:59Z 2024-11-12T04:16:53Z E8-15801 1 0 090000648066791e
FDA-2005-N-0464-0021 FDA Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs FDA-2005-N-0464 Notice of Extension re Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs; ReOpening of Comment Period Proposed Rule Extension of Comment Period 2007-02-08T05:00:00Z 2007 2 2007-02-07T05:00:00Z 2007-02-27T04:59:59Z 2016-11-10T15:32:42Z   0 0 0900006480450d0d
FDA-2005-N-0464-0020 FDA Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs FDA-2005-N-0464 Letter from FDA/CDER Response to National Committee on Vital Other Letter(s) 2007-01-29T05:00:00Z 2007 1     2016-12-13T21:15:43Z   0 0 0900006480450ca3
FDA-2005-N-0464-0015 FDA Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs FDA-2005-N-0464 See FDA-2005-N-0464-0014 Supporting & Related Material TR-Transcript 2007-01-12T05:00:00Z 2007 1     2009-04-15T23:58:47Z   0 0 0900006480450c43
FDA-2005-N-0464-0014 FDA Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs FDA-2005-N-0464 Transcript of Public Meeting: Proposed Changes to the National Drug Code (NDC) System, December 11, 2006 Other TR-Transcript 2007-01-12T05:00:00Z 2007 1     2017-07-24T15:11:28Z   0 0 0900006480450c42
FDA-2005-N-0464-0016 FDA Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs FDA-2005-N-0464 FDA/CDER - "Proposed Revised 21 CFR 207 Electronic Drug Registration and Listing Systems (e-DRLS)" - Testimony Other TS-Testimony 2007-01-12T05:00:00Z 2007 1     2017-01-18T17:37:35Z   0 0 0900006480450c44
FDA-2005-N-0464-0017 FDA Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs FDA-2005-N-0464 Testimony re FDA-2005-N-0464-0016 Supporting & Related Material Testimony 2007-01-12T05:00:00Z 2007 1     2016-12-13T20:44:03Z   0 0 0900006480450c45
FDA-2005-N-0464-0008 FDA Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs FDA-2005-N-0464 Notice of Extension re Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs; Public Meeting; Extension of Comment Period Proposed Rule Extension of Comment Period 2006-10-31T05:00:00Z 2006 10 2006-10-30T05:00:00Z 2007-01-27T04:59:59Z 2016-12-19T17:17:44Z   0 0 0900006480450c15
FDA-2005-N-0464-0006 FDA Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs FDA-2005-N-0464 REF 1 - OMB Changes re The September 30, 1993, Executive Order 12866 (E.O.) --Regulatory Planning and Review sets forth the Administration's principles and requirements for the Federal regulatory process Supporting & Related Material REF-Reference (internal unless indicated) 2006-09-08T04:00:00Z 2006 9     2017-07-24T14:15:25Z   0 0 0900006480450c08
FDA-2005-N-0464-0005 FDA Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs FDA-2005-N-0464 REF 1 - OMB Changes re The September 30, 1993, Executive Order 12866 (E.O.) --Regulatory Planning and Review sets forth the Administration's principles and requirements for the Federal regulatory process Supporting & Related Material REF-Reference (internal unless indicated) 2006-09-08T04:00:00Z 2006 9     2017-07-24T14:17:07Z   0 0 0900006480450c07
FDA-2005-N-0464-0007 FDA Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs FDA-2005-N-0464 REF 1 - OMB Changes re The September 30, 1993, Executive Order 12866 (E.O.) --Regulatory Planning and Review sets forth the Administration's principles and requirements for the Federal regulatory process Supporting & Related Material REF-Reference (internal unless indicated) 2006-09-08T04:00:00Z 2006 9     2017-07-24T14:12:42Z   0 0 0900006480450c09
FDA-2005-N-0464-0002 FDA Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs FDA-2005-N-0464 Proposed rule on Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs (Pages 201-300) Proposed Rule Notice of Proposed Rulemaking (NPRM) 2006-08-23T04:00:00Z 2006 8 2006-08-23T04:00:00Z 2006-11-28T04:59:59Z 2017-08-15T14:33:55Z   0 0 0900006480450bee
FDA-2005-N-0464-0001 FDA Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs FDA-2005-N-0464 Proposed rule on Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs (Pages 301-319) Proposed Rule Notice of Proposed Rulemaking (NPRM) 2006-08-23T04:00:00Z 2006 8 2006-08-23T04:00:00Z 2006-11-28T04:59:59Z 2017-08-15T14:32:51Z   0 0 0900006480450bce
FDA-2005-N-0464-0003 FDA Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs FDA-2005-N-0464 Proposed rule on Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs (Pages 1-100) Proposed Rule Notice of Proposed Rulemaking (NPRM) 2006-08-23T04:00:00Z 2006 8 2006-08-23T04:00:00Z 2006-11-28T04:59:59Z 2017-08-15T14:35:39Z   0 0 0900006480450bf2
FDA-2005-N-0464-0004 FDA Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs FDA-2005-N-0464 Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs (Pages 101-200) Proposed Rule Notice of Proposed Rulemaking (NPRM) 2006-08-23T04:00:00Z 2006 8 2006-08-23T04:00:00Z 2006-11-28T04:59:59Z 2016-03-14T19:19:42Z   0 0 0900006480450bf3

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options: 

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);